Thunberg U, Sällström J, Frost B M, Lönnerholm G, Sundström C
Department of Pathology, University Hospital, Uppsala, Sweden.
Diagn Mol Pathol. 1998 Jun;7(3):146-51. doi: 10.1097/00019606-199806000-00004.
The rearrangement of the immunoglobulin heavy chain (IgH) genes can be used as a marker of cell lineage and clonality. The polymerase chain reaction (PCR) technique using consensus primers for the IgH gene was used for remission and minimal residual disease (MRD) analysis in the follow-up of childhood acute lymphoblastic leukemia (ALL) of B-cell lineage. Single-strand conformational polymorphism (SSCP) was used to distinguish the specific clonal amplicons from the background. The Authors found that, in a series of 22 patients followed-up for 5.3 to 11.1 years, the PCR-SSCP technique could detect at least one rearrangement at initial diagnosis in 21 (95%). All patients who remained in continuous complete remission were PCR-SSCP negative at remission controls. Ten of the 22 patients had one or more bone marrow relapses. The PCR-SSCP method demonstrated MRD in three of them. In 6 of the 7 (86%) of patients with disease recurrence from whom samples were taken within 6 months before a clinically overt relapse, PCR-SSCP became positive. The Authors conclude that PCR-SSCP of a rearrangement marker might have a role as a convenient technique for monitoring emerging relapse. It may also detect unrelated clones or ongoing secondary recombination events during progression. However, PCR-SSCP is not sensitive enough to detect MRD in all patients in whom disease will later recur.
免疫球蛋白重链(IgH)基因重排可作为细胞谱系和克隆性的标志物。在B细胞系儿童急性淋巴细胞白血病(ALL)的随访中,使用针对IgH基因的共有引物的聚合酶链反应(PCR)技术进行缓解期和微小残留病(MRD)分析。单链构象多态性(SSCP)用于从背景中区分特定的克隆扩增子。作者发现,在对22例患者进行5.3至11.1年随访的系列研究中,PCR-SSCP技术在初始诊断时可在21例(95%)患者中检测到至少一种重排。所有持续完全缓解的患者在缓解期对照时PCR-SSCP均为阴性。22例患者中有10例发生了一次或多次骨髓复发。PCR-SSCP方法在其中3例中检测到了MRD。在临床明显复发前6个月内采集样本的7例(86%)疾病复发患者中,有6例PCR-SSCP变为阳性。作者得出结论,重排标志物的PCR-SSCP可能作为一种方便的技术用于监测复发的出现。它还可能在疾病进展过程中检测到无关克隆或正在进行的二次重组事件。然而,PCR-SSCP的敏感性不足以在所有后来会复发的患者中检测到MRD。